Tag: stem cell manufacturing market forecast

  • Stem Cell Manufacturing Market Forecast Reaching $30.27 Billion by 2029 at 12% CAGR

    Stem Cell Manufacturing Market Forecast Reaching $30.27 Billion by 2029 at 12% CAGR

    Discover trends, market shifts, and competitive outlooks for the stem cell manufacturing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

    #What Is the Current and Projected Market Size of the Stem Cell Manufacturing Market Through 2034?_x000D_

    The market size of stem cell manufacturing has seen considerable growth in the previous years. It is projected to rise from $17.5 billion in 2024 to $19.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.8%. Factors contributing to this growth in the past period include developments in biotechnology, initiatives for research and development, regulatory framework setup, investment in infrastructure, as well as clinical trials and therapeutic applications._x000D_

    _x000D_

    In the coming years, significant expansion is anticipated in the stem cell manufacturing market, with predictions suggesting a rise to $30.27 billion in 2029, reflecting a compound annual growth rate (CAGR) of 12.0%. The projected growth for this period is largely due to a surge in funding and investment, an increase in therapeutic applications, the advent of cell-based therapies, increased clinical trials and approvals, as well as custom and patient-specific remedies. Key trends for the forecast period encompass a focus on 3d bioprinting, growth in induced pluripotent stem cells (ipscs), integration with automation and robotics, standardization and scalability, as well as advancements in bioreactor technology._x000D_

    _x000D_

    #Download a free sample to assess the report’s scope and structure:#_x000D_

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9402&type=smp_x000D_

    _x000D_

    #Which Major Market Drivers Are Expected to Boost the Growth Potential of the Stem Cell Manufacturing Market?#_x000D_

    The anticipated expansion of the elderly demographic is predicted to spur growth in the stem cell manufacturing industry. This refers to people aged 65 and older, who often suffer from various illnesses due to decreased immunity and the impact of age. The risk of chronic diseases increases with age, and stem cell production can contribute to combating these illnesses. For example, data from the Population Reference Bureau – a Nonprofit organization based in Kenya – forecasted a significant growth in the American population aged 65 and older, from 58 million in 2022 to 82 million by 2050, marking a 47% increase. The proportion of this age group in the general population is also estimated to ascend from 17% to 23% within the same time frame. Therefore, the growth of the elderly population is fueling the expansion of the stem cell manufacturing industry._x000D_

    _x000D_

    #Which Key Market Segments Comprise the Stem Cell Manufacturing Market and Drive Its Revenue Growth?#_x000D_

    The stem cell manufacturing market covered in this report is segmented –_x000D_

    _x000D_

    1) By Product: Consumables, Instruments, Stem Cell Lines_x000D_

    2) By Application: Research Applications, Clinical Application, Cell And Tissue Banking Applications_x000D_

    3) By End User: Pharmaceutical And Biotechnology Companies, Academic Institutes, Research Laboratories And Contract Research Organizations, Hospitals And Surgical Centers, Cell And Tissue Banks, Other End Users_x000D_

    _x000D_

    Subsegments:_x000D_

    1) By Consumables: Media And Reagents, Cell Culture Vessels, Assay Kits_x000D_

    2) By Instruments: Bioreactors, Cell Counters, Flow Cytometers_x000D_

    3) By Stem Cell Lines: Embryonic Stem Cell Lines, Adult Stem Cell Lines, Induced Pluripotent Stem Cell Lines (iPSCs)_x000D_

    _x000D_

    #Request customized data on this market:#_x000D_

    https://www.thebusinessresearchcompany.com/customise?id=9402&type=smp_x000D_

    _x000D_

    #Which Areas Are Leading Regions in the Stem Cell Manufacturing Market Expansion Across the Globe?#_x000D_

    North America was the largest region in the stem cell manufacturing market in 2024. Europe was the second-largest region in the stem cell manufacturing market. The regions covered in the stem cell manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

    _x000D_

    #What Are the Key Market Trends in the Stem Cell Manufacturing Market Over the Coming Years?#_x000D_

    A significant trend in the stem cell manufacturing market is the progression of technology. Many players in the market are capitalizing on developments in technology to keep their competitive edge. As an example, Bluebird Bio Inc., a biotechnology company based in the United States, received approval from the U.S. Food and Drug Administration (FDA) for ZYNTEGLO in August 2022. This groundbreaking once-off gene therapy is now approved for beta-thalassemia treatment for those who require regular transfusions of red blood cells. A striking characteristic of this therapy is the ex-vivo process which incorporates a modified beta-globin gene into the patient’s hematopoietic stem cells, facilitating normal hemoglobin production levels. This innovative treatment’s main aim is to achieve independence from transfusions, significantly mitigating the treatment challenges encountered by those with beta-thalassemia. The approval of ZYNTEGLO marks a significant achievement in gene therapy, with the potential to provide a cure and improve the quality of life for those affected._x000D_

    _x000D_

    #View the full report here:#_x000D_

    https://www.thebusinessresearchcompany.com/report/stem-cell-manufacturing-global-market-report_x000D_

    _x000D_

    #How Is the Stem Cell Manufacturing Market Conceptually Defined?#_x000D_

    Stem cell manufacturing refers to the necessary technologies that allow stem cell tissue culture, a practice carried out in laboratories for therapeutic purposes, to be transferred to the clinic setting while simultaneously achieving control, reproducibility, automation, validation, and product safety._x000D_

    _x000D_

    #Purchase the full report and get a swift delivery:#_x000D_

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9402_x000D_

    _x000D_

    #About The Business Research Company:#_x000D_

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

    _x000D_

    #Get in touch with us:#_x000D_

    The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

    Americas +1 3156230293_x000D_

    Asia +44 2071930708_x000D_

    Europe +44 2071930708_x000D_

    Email us at info@tbrc.info_x000D_

    _x000D_

    #Follow us on:#_x000D_

    _x000D_

    LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Stem Cell Manufacturing Market Forecast 2025-2034: Growth Dynamics, Emerging Trends, and Strategic Opportunities

    Stem Cell Manufacturing Market Forecast 2025-2034: Growth Dynamics, Emerging Trends, and Strategic Opportunities

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    Which Major Market Drivers Are Expected to Boost the Growth Potential of the Stem Cell Manufacturing Market?

    The growing population of older adults is anticipated to boost the stem cell manufacturing market. The term “geriatric population” is used to describe individuals aged 65 or over. This age group is more susceptible to various diseases due to decreased immunity and aging. The stem cell manufacturing industry plays a crucial role in combating these age-related diseases, as the risk of chronic illnesses increases with age. To illustrate, the Population Reference Bureau, a non-profit organization based in Kenya, reported in January 2024 that by 2050, the American population aged 65 and older is projected to expand from 58 million in 2022 to 82 million, a surge of 47%. The proportion of this age group in relation to the total population is also anticipated to increase from 17% to 23% during this timeframe. Therefore, the increasing geriatric population is contributing to the expansion of the stem cell manufacturing market.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9402&type=smp

    #What is the Growth Potential of the Stem Cell Manufacturing Market, and How Will It Perform by 2034?

    Recently, there has been significant growth in the size of the stem cell manufacturing market. It is foreseen to expand from $17.5 billion in 2024 to $19.22 billion in 2025, displaying a compound annual growth rate (CAGR) of 9.8%. This progression during the historic period can be credited to advancements in biotechnology, efforts in research and development, clinical trials and therapeutic applications, the establishment of a regulatory framework, and investments into infrastructure.

    There is anticipation for substantial growth in the stem cell manufacturing market size within the upcoming years. It’s expected to inflate to a size of $30.27 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.0%. This projected growth within the forecast period can be linked to factors such as increased financial contributions and investments, the expansion of therapeutic applications, the advent of cellular therapies, an increase in clinical trials and approvals, and the adaptation of personalized and patient-specific treatments. Key trends to expect in the future include a focus on 3D bioprinting, an increase in induced pluripotent stem cells (ipscs), the integration of automation and robotics, standardization and scalability, and progress in bioreactor technology.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9402

    What Are the Key Market Innovations in theStem Cell Manufacturing Market Over the Coming Years?

    Technological innovation is a crucial factor driving the stem cell production market. Many of the market’s participants are utilizing advanced technologies to remain competitive. For instance, Bluebird Bio Inc., a biotech firm based in the United States, received approval from the U.S. Food and Drug Administration (FDA) for ZYNTEGLO in August 2022. This represents a pioneering gene therapy that has received approval for treating beta-thalassemia in patients who require regular red blood cell transfusions. Its unique ex-vivo method involves integrating a modified beta-globin gene into the patient’s hematopoietic stem cells, allowing them to produce normal hemoglobin levels. The goal of this innovative treatment is to achieve independence from transfusions, greatly reducing the treatment burden for those suffering from beta-thalassemia. The approval of ZYNTEGLO is a significant breakthrough in gene therapy and it may provide a cure, improving the quality of life for those affected.

    Who Are the Top Companies Driving Innovation and Growth in theStem Cell Manufacturing Market?

    Major companies operating in the stem cell manufacturing market include Thermo Fisher Scientific Inc., Merck Millipore, Stemcell Technologies, Fujifilm Holdings Corporation, Takara Bio Group, Lonza Group AG, Sartorius AG, Bio-Rad Laboratories, Becton Dickinson and Company, Bio-Techne Corporation, Miltenyi Biotec, Terumo BCT Inc., Corning Inc., Eppendorf AG, ViaCyte Inc., Merck KGaA, Danaher Corporation, Vericel Corporation, American Cryostem Corporation, Cellgenix GMBH, Aspen Neuroscience Inc., Magenta Therapeutics Inc, Pluristem Therapeutics Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., 3D Biomatrix Inc., Worthington Biochemical Corporation, Bico Group

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/stem-cell-manufacturing-global-market-report

    Which Key Market Segments Comprise the Stem Cell Manufacturing Market and Drive Its Revenue Growth?

    The stem cell manufacturing market covered in this report is segmented –

    1) By Product: Consumables, Instruments, Stem Cell Lines

    2) By Application: Research Applications, Clinical Application, Cell And Tissue Banking Applications

    3) By End User: Pharmaceutical And Biotechnology Companies, Academic Institutes, Research Laboratories And Contract Research Organizations, Hospitals And Surgical Centers, Cell And Tissue Banks, Other End Users

    Subsegments:

    1) By Consumables: Media And Reagents, Cell Culture Vessels, Assay Kits

    2) By Instruments: Bioreactors, Cell Counters, Flow Cytometers

    3) By Stem Cell Lines: Embryonic Stem Cell Lines, Adult Stem Cell Lines, Induced Pluripotent Stem Cell Lines (iPSCs)

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=9402&type=smp

    Which Regions Are Emerging as Leaders in the Stem Cell Manufacturing Market?

    North America was the largest region in the stem cell manufacturing market in 2024. Europe was the second-largest region in the stem cell manufacturing market. The regions covered in the stem cell manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Browse Through More Reports Similar to the Gobal Stem Cell Manufacturing Maret 2025, By The Business Research Company:

    Monoclonal Antibodies (MAs) Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/monoclonal-antibodies-global-market-report

    Neurodegenerative Disorder Therapeutics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

    Neurology Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • What’s Driving Growth in the Stem Cell Manufacturing Market? Insights into Key Trends and Opportunities

    What’s Driving Growth in the Stem Cell Manufacturing Market? Insights into Key Trends and Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What key factors are powering the surge in the stem cell manufacturing market right now?

    The market size for stem cell manufacturing has seen a robust increase in recent years. Expected to surge from $17.5 billion in 2024 to $19.22 billion in 2025, it will achieve a compound annual growth rate (CAGR) of 9.8%. This striking growth in the historic period is credited to advancements in biotechnology, initiatives in research and development, clinical trials, and the progress in therapeutic applications. Additionally, the establishment of a regulatory framework and investments in infrastructure have also contributed to this growth.

    How fast Is the stem cell manufacturing market expected to grow, and what’s its future value?

    In the coming years, the stem cell manufacturing market is projected to experience a swift expansion. It’s estimated to reach $30.27 billion by 2029, with a compound annual growth rate (CAGR) of 12.0%. The forecasted growth is predominantly driven by factors such as increased funding and investments, the expanding applications in therapeutics, the advent of cell-based therapies, a rise in clinical trials and approvals, and the development of tailored therapies based on individual patients. Key trends to watch for during this forecast period include enhancement in 3D bioprinting, the proliferation of induced pluripotent stem cells (ipscs), the integration of automation and robotics, advancements in bioreactor technology, and efforts towards standardization and scalability.

    Get your stem cell manufacturing market report here!

    https://www.thebusinessresearchcompany.com/report/stem-cell-manufacturing-global-market-report

    What are the leading drivers of growth in the stem cell manufacturing market?

    The escalating numbers of older adults—those age 65 and above, known as the geriatric population—is anticipated to significantly stimulate the stem cell manufacturing market. This older demographic is often beset by an array of health conditions due to declining immunity and advancing age. The likelihood of developing chronic diseases also increases with age, and stem cell manufacturing could be key in combating these illnesses. For example, projections from the Population Reference Bureau, a nonprofit organization located in Kenya, indicate that the numbers of Americans in this age bracket will jump from 58 million in 2022 to 82 million by 2050—an impressive 47% rise. Similarly, it is predicted that this demographic will constitute an ever-growing percentage of the entire population—rising from 17% to 23% within the same span. Therefore, the surging numbers of older adults are fueling the expansion of the stem cell manufacturing market.

    What are the key segments defining the stem cell manufacturing market?

    The stem cell manufacturing market covered in this report is segmented –

    1) By Product: Consumables, Instruments, Stem Cell Lines

    2) By Application: Research Applications, Clinical Application, Cell And Tissue Banking Applications

    3) By End User: Pharmaceutical And Biotechnology Companies, Academic Institutes, Research Laboratories And Contract Research Organizations, Hospitals And Surgical Centers, Cell And Tissue Banks, Other End Users

    Subsegments:

    1) By Consumables: Media And Reagents, Cell Culture Vessels, Assay Kits

    2) By Instruments: Bioreactors, Cell Counters, Flow Cytometers

    3) By Stem Cell Lines: Embryonic Stem Cell Lines, Adult Stem Cell Lines, Induced Pluripotent Stem Cell Lines (iPSCs)

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9402&type=smp

    Who are the key players steering the development of the stem cell manufacturing market?

    Major companies operating in the stem cell manufacturing market include Thermo Fisher Scientific Inc., Merck Millipore, Stemcell Technologies, Fujifilm Holdings Corporation, Takara Bio Group, Lonza Group AG, Sartorius AG, Bio-Rad Laboratories, Becton Dickinson and Company, Bio-Techne Corporation, Miltenyi Biotec, Terumo BCT Inc., Corning Inc., Eppendorf AG, ViaCyte Inc., Merck KGaA, Danaher Corporation, Vericel Corporation, American Cryostem Corporation, Cellgenix GMBH, Aspen Neuroscience Inc., Magenta Therapeutics Inc, Pluristem Therapeutics Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., 3D Biomatrix Inc., Worthington Biochemical Corporation, Bico Group

    What emerging trends are influencing the growth of the stem cell manufacturing market?

    The progression of technology plays a significant role within the stem cell manufacturing market trends. Industry participants are increasingly utilizing these advancements to maintain their market presence. For example, Bluebird Bio Inc., an American biotech company, announced in August 2022 that the U.S. Food and Drug Administration approved its ground-breaking one-time gene therapy, ZYNTEGLO, for patients needing regular red blood cell transfusions due to beta-thalassemia. A prominent feature of this treatment involves the ex-vivo method, in which a patient’s hematopoietic stem cells are integrated with a modified beta-globin gene, enabling normal hemoglobin production. ZYNTEGLO aims to achieve an independence from transfusions, consequently alleviating the medical challenges encountered by beta-thalassemia patients. The approval of this innovative therapy represents a pivotal moment in gene therapy, potentially offering a cure and heightening the quality of life for those impacted.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9402

    Which regions are most influential in expanding the stem cell manufacturing market?

    North America was the largest region in the stem cell manufacturing market in 2024. Europe was the second-largest region in the stem cell manufacturing market. The regions covered in the stem cell manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Browse Through More Similar Reports By The Business Research Company:

    Monoclonal Antibodies (MAs) Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/monoclonal-antibodies-global-market-report

    Neurodegenerative Disorder Therapeutics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

    Neurology Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: